Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 29 Nov 2024

Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report

in Cancer Immunity and Immunotherapy

Chiara Bernardi
Yan Beauverd
Thien An Tran
Marie Maulini
Maria Mappoura
Sarah Morin
Federico Simonetta
Anne Cairoli
Holger W. Auner
Kaveh Samii

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495233

1,200 views
2 citations

Original Research

Published on 29 Nov 2024

Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma

in Cancer Immunity and Immunotherapy

Yu Miao
Meng Dong
Qiyin Zhou
Julia Thiel
Na Li
Ying Cai
Dan Yuan
Haitao Wang
Su-Han Jin
Hua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513076

1,489 views

Review

Published on 29 Nov 2024

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy

in Cancer Immunity and Immunotherapy

Hong-Xia Li
Yu-Wen Gong
Pi-Jun Yan
Yong Xu
Gang Qin
Wei-Ping Wen
Fang-Yuan Teng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1453753

1,136 views

Original Research

Published on 29 Nov 2024

The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy

in Cancer Immunity and Immunotherapy

Enzhao Wang
Kuiwu Ren
Xiangyu Wang
Sen Du
Xiang Gao
Wang Niu
Chenyue Guan
Xue Liu
Panpan Wu
Chunlong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505966

781 views
1 citation

Review

Published on 29 Nov 2024

Breaking barriers: advancing cellular therapies in autoimmune disease management

in Cancer Immunity and Immunotherapy

Yanhong Fu
Chunjing Feng
Shan Qin
Zhiyao Xing
Chong Liu
Zichuan Liu
Hongjian Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1503099

2,253 views

Original Research

Published on 29 Nov 2024

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study

in Cancer Immunity and Immunotherapy

Na Song
Yuee Teng
Jing Shi
Zan Teng
Bo Jin
Jinglei Qu
Lingyun Zhang
Ping Yu
Lei Zhao
Jin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481326

912 views

Original Research

Published on 29 Nov 2024

ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia

in Cancer Immunity and Immunotherapy

Nathaly Poveda-Garavito
Carlos A. Orozco Castaño
Yulieth Torres-Llanos
Nataly Cruz-Rodriguez
Rafael Parra-Medina
Sandra Quijano
Jovanny Zabaleta
Alba Lucia Combita

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473909

1,165 views

Review

Published on 29 Nov 2024

Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights

in Cancer Immunity and Immunotherapy

Jinlong Wan
Jianzhong Zhao
Xiaolu Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502257

1,019 views

Review

Published on 29 Nov 2024

Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation

in Cancer Immunity and Immunotherapy

Lukáš Lacina
Michal Kolář
Lucie Pfeiferová
Peter Gál
Karel Smetana

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403570

2,149 views
1 citation

Original Research

Published on 29 Nov 2024

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Zhenyun Yang
Weijie Wu
Zhiwen Hu
Yizhen Fu
Zili Hu
Yangxun Pan
Juncheng Wang
Jinbin Chen
Zhongguo Zhou
Yaojun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494520

1,026 views

Original Research

Published on 29 Nov 2024

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer

in Cancer Immunity and Immunotherapy

Xiaofang Li
Zhiling Pan
Tiankuo Luan
Qian Xiao
Liuying Li
Qianxue Wu
Guoqing Yao
Xiang Zhang
Daqiang Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493673

1,123 views

Original Research

Published on 29 Nov 2024

Global lncRNA expression signature in pre-metastatic lung and their regulatory effects in pulmonary metastasis

in Cancer Immunity and Immunotherapy

Huifang Shi
Peng Wang
Jiaan Wang
Lei Chen
Yan Qin
Jie Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506561

630 views

Review

Published on 29 Nov 2024

Unravelling the druggability and immunological roles of the SOCS-family proteins

in Cancer Immunity and Immunotherapy

Dylan M. Lynch
Beth Forrester
Thomas Webb
Alessio Ciulli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1449397

1,632 views

Case Report

Published on 29 Nov 2024

Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study

in Cancer Immunity and Immunotherapy

Federico Rebaudi
Alberto Rebaudi
Alfredo De Rosa
Alberto Luigi Rebaudi
Silvia Pesce
Marco Greppi
Marco Roghi
Maurizio Boggio
Simona Candiani
Emanuela Marcenaro

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477477

616 views

Review

Published on 28 Nov 2024

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes

in Cancer Immunity and Immunotherapy

Jiexi Yan
Lu Yang
Qingmiao Ren
Chan Zhu
Haiyun Du
Zhouyu Wang
Yaya Qi
Xiaohong Xian
Dongsheng Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471273

2,515 views
1 citation

Original Research

Published on 28 Nov 2024

Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model

in Cancer Immunity and Immunotherapy

Xiao Guo
Yuyan Cao
Xinlin Shi
Jiaying Xing
Chuanbo Feng
Tao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462953

1,081 views

Navigation group

Articles

Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report

Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy

The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy

Breaking barriers: advancing cellular therapies in autoimmune disease management

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study

ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia

Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights

Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer

Global lncRNA expression signature in pre-metastatic lung and their regulatory effects in pulmonary metastasis

Unravelling the druggability and immunological roles of the SOCS-family proteins

Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes

Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model